Wall Street Thinks This Small-Cap Stock Can Double in Value
The fickle nature of the stock market can send stocks plunging or soaring much more than is justified. That's because the psychology of investing includes the emotions of fear and greed, which can sometimes cloud the judgment of the market overall.
This arguably was demonstrated when shares of medical device maker AngioDynamics (NASDAQ: ANGO) plummeted 27% on the day of its fiscal third-quarter earnings release recently. Let's dig into three reasons this sell-off could have been massively overdone.
With a $400 million market capitalization, AngioDynamics is one of the smaller publicly traded medical device companies. But while few retail investors are likely familiar with the stock, many healthcare professionals are well acquainted with the company's products.
Source Fool.com
